Details for Patent: 8,575,137
✉ Email this page to a colleague
Summary for Patent: 8,575,137
Title: | Composition for inhalation |
Abstract: | The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000. |
Inventor(s): | Govind; Nayna (Loughborough, GB), Marlow; Maria (Loughborough, GB) |
Assignee: | AstraZeneca AB (Macclesfield, GB) |
Application Number: | 13/411,939 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,575,137 |
Patent Claim Types: see list of patent claims | Composition; Compound; Use; Delivery; |
Drugs Protected by US Patent 8,575,137
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,575,137
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Sweden | 0200312 | Feb 1, 2002 |
International Family Members for US Patent 8,575,137
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 423552 | ⤷ Try a Trial | |||
Austria | 463241 | ⤷ Try a Trial | |||
Australia | 2003206289 | ⤷ Try a Trial | |||
Brazil | 0307193 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |